Paraneoplastic Cardiac Involvement in Renal Cell Carcinoma With Dermatomyositis Sine Dermatitis

REFERENCES

1. 1.↵
   1. Auché M

   Des névrites périphériques chez les cancéreux. Rev Med (Paris). 1890; 10: 785- 807.

   OpenUrl
2. 2.↵
   1. Bilynsky BT,
   2. Dzhus MB,
   3. Litvinyak RI

   The conceptual and clinical problems of paraneoplastic syndrome in oncology and internal medicine. Exp Oncol. 2015 6; 37 2: 82- 88. pmid:26112932

   OpenUrlPubMed
3. 3.↵
   1. Callen JP,
   2. Hyla JF,
   3. Bole GG Jr,.,
   4. Kay DR

   The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol. 1980 3; 116 3: 295- 298. pmid:7369745

   OpenUrlCrossRefPubMedWeb of Science
4. 4.
   1. Bendewald MJ,
   2. Wetter DA,
   3. Li X,
   4. Davis MD

   Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010 1; 146 1: 26- 30. doi: 10.1001/archdermatol.2009.328. pmid:20083689

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Iaccarino L,
   2. Ghirardello A,
   3. Bettio S,
   4. et al.

   The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun. 2014 Feb-Mar; 48-49: 122- 127. doi: 10.1016/j.jaut.2013.11.005. pmid:24467910

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Dimachkie MM,
   2. Barohn RJ,
   3. Amato AA

   Idiopathic inflammatory myopathies. Neurol Clinc. 2014 8; 32 3: 595- 628, vii. doi: 10.1016/j.ncl.2014.04.007.

   OpenUrlCrossRef
7. 7.↵
   1. Huang YL,
   2. Chen YJ,
   3. Lin MW,
   4. et al.

   Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol. 2009 10; 161 4: 854- 860. doi: 10.1111/j.1365-2133.2009.09274.x. pmid:19558555

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Kuo CF,
   2. See LC,
   3. Yu KH,
   4. et al.

   Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol. 2011 12; 165 6: 1273- 1279. doi: 10.1111/j.1365-2133.2011.10595.x. pmid:21895620

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Oppenheim H

   Zur dermatomyositis. Berl Klin Wochenschrift. 1899; 36: 805- 807.

   OpenUrl
10. 10.↵
    1. Lundberg IE

    The heart in dermatomyositis and polymyositis. Rheumatology (Oxford). 2006 10; 45 Suppl 4:iv18-iv21.
11. 11.↵
    1. Zhang L,
    2. Wang GC,
    3. Ma L,
    4. Zu N

    Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol. 2012 11; 35 11: 686- 691. doi: 10.1002/clc.22026. pmid:22847365

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Targoff IN,
    2. Mamyrova G,
    3. Trieu EP,
    4. et al.

    Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006 11; 54 11: 3682- 3689. pmid:17075819

    OpenUrlCrossRefPubMedWeb of Science
13. 13.
    1. Kaji K,
    2. Fujimoto M,
    3. Hasegawa M,
    4. et al.

    Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007 1; 46 1: 25- 28. pmid:16728436

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Trallero-Araguás E,
    2. Rodrigo-Pendás JÁ,
    3. Selva-O'Callaghan A,
    4. et al.

    Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum. 2012 2; 64 2: 523- 532. doi: 10.1002/art.33379. pmid:21953614

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Dalakas MC,
    2. Hohlfeld R

    Polymyositis and dermatomyositis. Lancet. 2003 9 20; 362 9388: 971- 982. pmid:14511932

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Shimizu J

    Malignancy-associated myositis [in Japanese]. Brain Nerve. 2010 4; 62 4: 427- 432. pmid:20420184

    OpenUrlPubMed
17. 17.↵
    1. Erlacher P,
    2. Lercher A,
    3. Falkensammer J,
    4. et al.

    Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta. 2001 4; 306 1-2: 27- 33. pmid:11282091

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Kiely PD,
    2. Bruckner FE,
    3. Nisbet JA,
    4. Daghir A

    Serum skeletal troponin I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin I. Ann Rheum Dis. 2000 9; 59 9: 750- 751. pmid:11023449

    OpenUrlFREE Full Text
19. 19.↵
    1. Pavo N,
    2. Raderer M,
    3. Hülsmann M,
    4. et al.

    Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Heart. 2015 12; 101 23: 1874- 1880. doi: 10.1136/heartjnl-2015-307848. pmid:26416836

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Venneri L,
    2. Calichio F,
    3. Manivarmane R,
    4. et al.

    Subclinical myocardial dysfunction in cancer patients: is there a direct effect of tumour growth? Eur Heart J Cardiovasc Imaging. 2015 5; 16 (Suppl 1):ii127.
21. 21.↵
    1. Mastaglia FL,
    2. Phillips BA

    Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am. 2002 11; 28 4: 723- 741. pmid:12510664

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Motzer RJ,
    2. Agarwal N,
    3. Beard C,
    4. et al.

    NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw. 2009 6; 7 6: 618- 630. pmid:19555584

    OpenUrlAbstract/FREE Full Text